Cargando…

Serum cystatin C predicts the risk of non-ST-elevation acute coronary syndrome

OBJECTIVE: Inflammation markers have been proposed as the predictors of adverse cardiac events in patients with non-ST-elevation acute coronary syndrome (NSTE-ACS). This study aimed to investigate prognostic value of serum cystatin C (Cys-C) for NSTE-ACS patients. METHODS: Cys-C, neutrophil to lymph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Hao, Xiao, Dongping, Tang, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693110/ https://www.ncbi.nlm.nih.gov/pubmed/38041201 http://dx.doi.org/10.1186/s13019-023-02465-1

Ejemplares similares

Association of Cystatin C with Metabolic Syndrome and Its Prognostic Performance in Non-ST-Segment Elevation Acute Coronary Syndrome with Preserved Renal Function
por: Mao, Qi, et al.
Publicado: (2019)

Serum cystatin C levels relate to no-reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction
por: Cheng, Chao, et al.
Publicado: (2019)

Cystatin C in Acute Coronary Syndrome
por: Lodh, Moushumi, et al.
Publicado: (2013)

Association of serum cystatin C levels with acute coronary syndrome in patients of advanced age
por: Huang, Qingyu, et al.
Publicado: (2019)

Cystatin C in the prognostic stratification of patients with an acute coronary syndrome
por: Lago, A Lopez, et al.
Publicado: (2007)

Elevated Serum Levels of Soluble ST2 Are Associated With Plaque Vulnerability in Patients With Non-ST-Elevation Acute Coronary Syndrome
por: Luo, Guqing, et al.
Publicado: (2021)

Non-ST elevation acute coronary syndrome in the elderly
por: Díez-Villanueva, Pablo, et al.
Publicado: (2020)

Hypertension and cystatin C account for sex differences in serum homocysteine levels in acute coronary syndrome subjects with normal serum creatinine
por: Shang, Kun, et al.
Publicado: (2023)

Continuum of Care for Acute Coronary Syndrome: Optimizing Treatment for ST-Elevation Myocardial Infarction and Non–St-Elevation Acute Coronary Syndrome
por: Gibler, W. Brian, et al.
Publicado: (2018)

Correlations of serum cystatin C and glomerular filtration rate with vascular lesions and severity in acute coronary syndrome
por: Zhang, Jinjin, et al.
Publicado: (2017)

Leukocyte Rho kinase activity and serum cystatin C affect cardiovascular events in acute coronary syndrome
por: Ma, Li, et al.
Publicado: (2020)

Serum Cystatin C as a Biomarker for Predicting Coronary Artery Disease in Diabetes
por: Oh, Jee-Young
Publicado: (2010)

Cystatin C for Risk Stratification in Patients After an Acute Coronary Syndrome
por: Correa, Simon, et al.
Publicado: (2018)

Long-term prognostic impact of cystatin c on acute coronary syndrome octogenarians with diabetes mellitus
por: Fu, Zhenhong, et al.
Publicado: (2013)

Value of GRACE and SYNTAX scores for predicting the prognosis of patients with non-ST elevation acute coronary syndrome
por: Wang, Xiao-Feng, et al.
Publicado: (2021)

Elevated Serum Cystatin C and Decreased Cathepsin S/Cystatin C Ratio Are Associated with Severe Peripheral Arterial Disease and Polyvascular Involvement
por: Nagy, Előd Ernő, et al.
Publicado: (2022)

Trials, registries and guidelines for non-ST-elevation acute coronary syndromes
por: Verheugt, F. W. A.
Publicado: (2013)

Diffuse ST-segment elevation beyond acute coronary syndrome
por: Zhu, Hai, et al.
Publicado: (2023)

Effect of COVID-19 on acute treatment of ST-segment elevation and Non-ST-segment elevation acute coronary syndrome in northwestern Switzerland
por: Boeddinghaus, Jasper, et al.
Publicado: (2020)

Prognostic implication of serum glycated albumin for patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention
por: Liu, Chi, et al.
Publicado: (2022)

GRACE and TIMI risk scores in predicting the angiographic severity of non-ST elevation acute coronary syndrome
por: Roy, Sharadindu Shekhar, et al.
Publicado: (2018)

Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes
por: Røysland, Ragnhild, et al.
Publicado: (2012)

Aggressive therapy for non-ST elevation acute coronary syndromes is highly effective
por: Santos, RA, et al.
Publicado: (2001)

Cognitive Decline in Older Patients With Non‐ST Elevation Acute Coronary Syndrome
por: Gu, Sophie Z., et al.
Publicado: (2019)

Safety of Antiplatelet Pretreatment in Non-ST-segment Elevation Acute Coronary Syndrome
por: Torres-Ruiz, G, et al.
Publicado: (2023)

Predictors of coronary collaterals in patients with non ST-elevated acute coronary syndrome: the paradox of the leukocytes
por: Tenekecioglu, Erhan, et al.
Publicado: (2014)

Fibrinogen-to-Albumin Ratio Predicts Postcontrast Acute Kidney Injury in Patients with Non-ST Elevation Acute Coronary Syndrome after Implantation of Drug-Eluting Stents
por: Qiao, Yong, et al.
Publicado: (2022)

Relationship between serum cystatin C and polycystic ovary syndrome
por: Gozashti, Mohammad Hossein, et al.
Publicado: (2013)

Role of the ECG in initial acute coronary syndrome triage: primary PCI regardless presence of ST elevation or of non-ST elevation
por: IJkema, B. B. L. M., et al.
Publicado: (2014)

Tissue characterization of non-culprit intermediate coronary lesions in non ST elevation acute coronary syndromes
por: Elghawaby, Helmy Hassan, et al.
Publicado: (2018)

Prognostic value of plasma ST2 in patients with non-ST segment elevation acute coronary syndrome
por: Kokkoz, Çağrı, et al.
Publicado: (2018)

Serum neutrophil gelatinase-associated lipocalin has an advantage over serum cystatin C and glomerular filtration rate in prediction of adverse cardiovascular outcome in patients with ST-segment elevation myocardial infarction
por: Barbarash, Olga L., et al.
Publicado: (2017)

The Triglyceride-Glucose Index Predicts Coronary Artery Disease Severity and Cardiovascular Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome
por: Mao, Qi, et al.
Publicado: (2019)

Serum cystatin C levels to predict serum concentration of digoxin in Japanese patients
por: Nakamura, Tsutomu, et al.
Publicado: (2006)

Biomarker of Collagen Turnover (C‐Terminal Telopeptide) and Prognosis in Patients With Non‐ST‐Elevation Acute Coronary Syndromes
por: Zelniker, Thomas A., et al.
Publicado: (2019)

High cystatin C levels predict long‐term mortality in patients with ST‐segment elevation myocardial infarction undergoing late percutaneous coronary intervention: A retrospective study
por: Chen, Yuewu, et al.
Publicado: (2019)

Integral assistance process implantation for ST-elevated acute coronary syndrome
por: Rodriguez-Yañez, JC, et al.
Publicado: (2012)

Treatment of acute coronary syndrome without ST-segment elevations in the elderly
por: Oliveira, GMM, et al.
Publicado: (2005)

ST-Segment Elevation in the Setting of Diabetic Ketoacidosis: Is It Acute Coronary Syndrome?
por: Wray, Jesse, et al.
Publicado: (2020)

ANMCO POSITION PAPER: Timing of coronary angiography in non-ST-segment elevation acute coronary syndromes
por: Murrone, Adriano, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jm1bbhqnaqbur863v1q289t2ak